News & Updates

Pinch strength predicts mild cognitive impairment in patients with CVD

04 Jun 2020

Pinch strength is an independent predictor of mild cognitive impairment (MCI) in patients with cardiovascular diseases (CVDs), a recent study has found.

Pinch strength predicts mild cognitive impairment in patients with CVD

04 Jun 2020

Metformin counters risks associated with diabetes in NASH cirrhosis patients

04 Jun 2020 by

Type 2 diabetes mellitus (T2DM) contributes to a heightened risk of death, hepatic decompensation, and hepatocellular carcinoma (HCC) among patients with nonalcoholic steatohepatitis (NASH) and cirrhosis, but the good news is that metformin may cut the risk of these adverse outcomes, a study has found.

Metformin counters risks associated with diabetes in NASH cirrhosis patients

04 Jun 2020

HbA1c grading tied to drug resistance in TB patients with T2DM

04 Jun 2020

HbA1c grading influences the risk of developing isoniazid resistance and multidrug resistance (MDR) in tuberculosis (TB) infected patients with type 2 diabetes mellitus (T2DM), a study suggests.

HbA1c grading tied to drug resistance in TB patients with T2DM

04 Jun 2020

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

03 Jun 2020 by

Once-daily 14 mg oral semaglutide yields greater reduction in HbA1c and body weight than weekly 0.75 mg subcutaneous dulaglutide and is well tolerated in a Japanese population with uncontrolled type 2 diabetes (T2D), according to the PIONEER 10 study.

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

03 Jun 2020

Serodiscordant condomless anal intercourse common among young men living with HIV

03 Jun 2020

Condomless anal intercourse (CAI), even among serodiscordant (SD-CAI) participants, is common among young, gay, bisexual, and other men who have sex with men (YGBMSM) living with HIV with detectable viral loads, a recent study has shown.

Serodiscordant condomless anal intercourse common among young men living with HIV

03 Jun 2020

Psychiatric comorbidities frequent among transgender teens

03 Jun 2020 by

There is a high incidence of psychiatric comorbidities among gender nonconforming teenagers, with about two-thirds and one-third experiencing depression and anxiety, respectively, according to a study presented at ENDO 2020.

Psychiatric comorbidities frequent among transgender teens

03 Jun 2020

COVID-19 mortality: Are men more vulnerable than women?

03 Jun 2020

More men than women die from SARS-CoV-2 infection, although it remains uncertain whether this difference is driven by biological dissimilarities between the sexes, or disparities in behavioural habits or in rates of comorbidities, according to a study.

COVID-19 mortality: Are men more vulnerable than women?

03 Jun 2020

Long-term radioiodine treatment effective in toxic multinodular goiter

03 Jun 2020

Treatment with 15 mCi of radioiodine (RAI) leads to low hypothyroidism rates in adult patients with toxic multinodular goiter (TMNG), with high cure rates and significant volume reduction, according to a study. This effect persists in the long term.

Long-term radioiodine treatment effective in toxic multinodular goiter

03 Jun 2020

Limited English literacy leads to medication nonadherence among elderly Singaporeans

03 Jun 2020 by

Older Singaporeans with limited English health literacy (EHL) are more likely to report uncertainty as regards taking medications correctly compared with those with adequate EHL, according to a study. Elderly people with limited EHL have difficulty understanding the information on prescription medication labels (PMLs), which then contributes to medication nonadherence.

Limited English literacy leads to medication nonadherence among elderly Singaporeans

03 Jun 2020

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

03 Jun 2020

The glucagon-like peptide-1 (GLP-1) receptor agonist (RA) dulaglutide shows highly consistent effectiveness on glycated haemoglobin (HbA1c) and body weight reduction in patients with type 2 diabetes (T2D), reveals a study. Its effectiveness remains significant even in subgroups of patients poorly represented in randomized controlled trials (RCTs).

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

03 Jun 2020

News & Updates

Filter by Specialty:

Specialty:

Pinch strength predicts mild cognitive impairment in patients with CVD

Pinch strength predicts mild cognitive impairment in patients with CVD

Metformin counters risks associated with diabetes in NASH cirrhosis patients

Metformin counters risks associated with diabetes in NASH cirrhosis patients

HbA1c grading tied to drug resistance in TB patients with T2DM

HbA1c grading tied to drug resistance in TB patients with T2DM

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

PIONEER 10: Oral semaglutide beats dulaglutide in Asian patients with T2D

Serodiscordant condomless anal intercourse common among young men living with HIV

Serodiscordant condomless anal intercourse common among young men living with HIV

Psychiatric comorbidities frequent among transgender teens

Psychiatric comorbidities frequent among transgender teens

COVID-19 mortality: Are men more vulnerable than women?

COVID-19 mortality: Are men more vulnerable than women?

Long-term radioiodine treatment effective in toxic multinodular goiter

Long-term radioiodine treatment effective in toxic multinodular goiter

Limited English literacy leads to medication nonadherence among elderly Singaporeans

Limited English literacy leads to medication nonadherence among elderly Singaporeans

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients

Dulaglutide shows consistent efficacy in reducing HbA1c, body weight in T2D patients